Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Eurocell (ECEL) by Steve Moore in ShareProphets
- Avoid DFS Furniture (DFS) by Steve Moore in ShareProphets
- Avoid Focusrite (TUNE) by Steve Moore in ShareProphets
- Overweight Sage Group (SGE) by JP Morgan
- Sector Perform Sabre Insurance Group (SBRE) by RBC Capital
- Overweight Centrica (CNA) by JP Morgan
- Hold BP (BP.) by HSBC
- Buy Softcat (SCT) by Berenberg
- Buy Eurocell (ECEL) by Berenberg
- Buy Essentra (ESNT) by Berenberg
- Buy Rockhopper Exploration (RKH) by Canaccord Genuity
- Speculative Buy Atlantic Lithium Limited NPV (DI) (ALL) by Canaccord Genuity
- Buy YouGov (YOU) by Canaccord Genuity
- Buy Softcat (SCT) by Shore Capital
- Buy Atalaya Mining (ATYM) by Canaccord Genuity
- Buy PCI-PAL (PCIP) by Canaccord Genuity
- Buy Trainline (TRN) by Canaccord Genuity
- Hold Tinybuild Inc. (DI) (TBLD) by Shore Capital
- Buy Wickes Group (WIX) by Canaccord Genuity
- Hold Clarkson (CKN) by Canaccord Genuity
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,440 open tips for GSK (GSK)
| Latest Bid : 1,955.50p | Latest Ask : 1,956.50p |
| High Today : 1,968.50p | Low Today : 1,940.00p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 5,514,346 | MKT Cap : £80848.23M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Underweight | JP Morgan | Premium Only | 2025-07-18 12:01:00 18/07/2025 | -47.43% |
| Reduce | HSBC | Premium Only | 2025-07-11 07:22:00 11/07/2025 | -34.01% |
| Hold | Deutsche Bank | Premium Only | 2025-07-08 13:16:00 08/07/2025 | 4.17% |
| Neutral | Goldman Sachs | Premium Only | 2025-06-30 06:08:00 30/06/2025 | – |
| Buy | Simon Watkins | Premium Only | 2025-06-16 10:15:00 16/06/2025 | 30.03% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.52% | 16/03/2026 |
| Latest Bid : 1,955.50p | Latest Ask : 1,956.50p |
| High Today : 1,968.50p | Low Today : 1,940.00p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 5,514,346 | MKT Cap : £80848.23M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Underweight | JP Morgan | Premium Only | 2025-07-18 12:01:00 18/07/2025 | -47.43% |
| Reduce | HSBC | Premium Only | 2025-07-11 07:22:00 11/07/2025 | -34.01% |
| Hold | Deutsche Bank | Premium Only | 2025-07-08 13:16:00 08/07/2025 | 4.17% |
| Neutral | Goldman Sachs | Premium Only | 2025-06-30 06:08:00 30/06/2025 | – |
| Buy | Simon Watkins | Premium Only | 2025-06-16 10:15:00 16/06/2025 | 30.03% |